2000

Recent Patents on Anti-Cancer Drug Discovery - Previous Issues

Volume 19, Issue 5

Most Cited Most Cited RSS feed

- Gefitinib: An Updated Review of its Role in the Cancer Management, its Nanotechnological Interventions, Recent Patents and Clinical Trials
  
  Authors: Pankaj Kumar, Bharti Mangla, Shamama Javed, Waquar Ahsan, Pankaj Musyuni, Aarif Ahsan and Geeta Aggarwal
- Research and Patents Status of Selected Phytochemicals Against Cancer: How Close and How Far?
  
  Authors: Homa Fatma and Hifzur R Siddique
- The Patent Landscape of BRAF Target and KRAS Target
  
  Authors: Hai-Long Zhang and Yongxia Li
- Understanding and Targeting the Epigenetic Regulation to Overcome EGFR-TKIs Resistance in Human Cancer
  
  Authors: Lan Sun, Lingyue Gao, Yingxi Zhao, Yuqing Wang, Qianhui Xu, Yiru Zheng, Jiali Chen, He Wang and Lihui Wang
- Prospective Challenges for Patenting and Clinical Trials of Anticancer Compounds from Natural Products: Coherent Review
  
  Authors: Ankit Sahoo, Ashok K. Mandal, Mayank Kumar, Khusbu Dwivedi and Deepika Singh
- The Efficacy and Safety of Anlotinib Alone and in Combination with Other Drugs in Previously Treated Advanced Thymic Epithelia Tumors: A Retrospective Analysis
  
  Authors: Shuo Li, Haiyan Zhou, Xiqin Zhang, Bing Bu, Rongjie Tao, Hui Zhang and Jinming Yu
- Gene Expression Network and Circ_0008012 Promote Progression in MLL/AF4 Positive Acute Lymphoblastic Leukemia
  
  Authors: Yan-Lai Tang, Jia-Yin Su, Jie-Si Luo, Li-Dan Zhang, Li-Min Zheng, Cong Liang, Li-Na Wang, Yu Li, Zhong Fan, Dan-Ping Huang, Panpan Sun, Zhenhua Luo, Ning Hao Qi, Jing-Jing Lan, Xiao-Li Zhang, Li-Bin Huang and Xue-Qun Luo
More Less

This is a required field

Please enter a valid email address

Approval was a Success

Invalid data

An Error Occurred

Approval was partially successful, following selected items could not be processed due to error

Please enter a valid_number test